Thrivent Financial For Lutherans Bluebird Bio, Inc. Transaction History

Thrivent Financial For Lutherans

  • $52.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$16.59 - $33.89 $501,996 - $1.03 Million
-30,259 Closed
0 $0
Q3 2020

Nov 10, 2020
SELL
$34.44 - $43.75 $403,567 - $512,662
-11,718 Reduced 27.92%
30,259 $1.63 Million
Q1 2020

May 15, 2020
BUY
$26.16 - $63.5 $876,752 - $2.13 Million
33,515 Added 396.06%
41,977 $1.93 Million
Q4 2019

Feb 13, 2020
BUY
$46.96 - $61.67 $397,375 - $521,851
8,462 New
8,462 $742,000

Others Institutions Holding BLUE

# of Institutions
150
Shares Held
63.4M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $708M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email